1998
DOI: 10.1046/j.1365-2559.1998.00565.x
|View full text |Cite
|
Sign up to set email alerts
|

Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases

Abstract: Our results emphasize the importance of being aware of synovial sarcoma as a possible primary pleural malignancy, especially in a young patient with a localized mass. In addition, the presence of bcl-2 protein perhaps represents a useful marker in distinguishing synovial sarcoma, especially monophasic variants, from mesothelioma within a panel of antibodies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
70
0
5

Year Published

1999
1999
2008
2008

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 99 publications
(76 citation statements)
references
References 27 publications
1
70
0
5
Order By: Relevance
“…Our radiologic images, documented in a recent review, 12 support the diagnosis of primary pulmonary and mediastinal synovial sarcoma. On chest radiographs, the lesion is typically uniform with well-circumscribed rounded or lobu- lated borders [13][14][15] with mediastinal shift in some patients. 16 Computed tomography demonstrates a well-defined homogeneous or heterogeneously enhancing mass containing necrotic areas and soft tissue components (Figure 1).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our radiologic images, documented in a recent review, 12 support the diagnosis of primary pulmonary and mediastinal synovial sarcoma. On chest radiographs, the lesion is typically uniform with well-circumscribed rounded or lobu- lated borders [13][14][15] with mediastinal shift in some patients. 16 Computed tomography demonstrates a well-defined homogeneous or heterogeneously enhancing mass containing necrotic areas and soft tissue components (Figure 1).…”
Section: Discussionmentioning
confidence: 99%
“…16 Computed tomography demonstrates a well-defined homogeneous or heterogeneously enhancing mass containing necrotic areas and soft tissue components (Figure 1). Ipsilateral pleural effusion is common, 5,[13][14][15][16] while mediastinal lym-phadenopathy is rare. 13 Sarcomas arising in the chest wall closely match the imaging characteristics of soft tissue synovial sarcoma with cortical bone destruction, tumor calcification and/or invasion into chest wall musculature, 17,18 features not observed on imaging in our study.…”
Section: Discussionmentioning
confidence: 99%
“…13,26 Chilosi 4 found that synovial sarcoma was Bcl-2 positive. Analogously, Nicholson 18 and Suster 25 found Bcl-2 positivity in 100% of synovial sarcomas. Segers 23 and Nakanishi 17 found that synovial sarcoma could be also Bcl-2 negative.…”
Section: Discussionmentioning
confidence: 85%
“…However, there is growing evidence that synovial sarcoma may develop as a primary tumour in the pleura. [15][16][17][18][19][20] In this regard during the last five years (2001)(2002)(2003)(2004)(2005), 3209 malignant mesotheliomas were certified by the French Mesothelioma panel (Mesopath group), 353 were sarcomatoid mesotheliomas (11%). Among sarcomatoid mesotheliomas, 54 were poorly differentiated, pleomorphic tumours (1.7% of all malignant mesotheliomas, 14% of sarcomatoid mesotheliomas).…”
mentioning
confidence: 99%